Alabama mother Marquita Smiley began taking the generic form of anti-nausea drug Zofran (ondansetron) regularly during her first trimester to treat debilitating morning sickness—but when her son Zaidan was born with a critically underdeveloped heart, necessitating open heart surgery at just 3 days old, Marquita started to wonder whether...
Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL
In March 2016, with more than 200 lawsuits pending in the Zofran (ondansetron) federal multi-district litigation (“MDL”) in the District of Massachusetts, plaintiffs submitted their proposal on the sequence and effect of “Master Pleadings.” In a sequence of master pleadings, usually created for administrative reasons, master complaints collate claims brought in each case...
Louisiana Family Files Zofran (ondansetron) Lawsuit over Heart Defects
In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy...
Zofran (ondansetron) MDL Continues to Grow
More and more parents are filing lawsuits against GlaxoSmithKline LLC (“GSK”), maker of anti-nausea drug Zofran (ondansetron), after their children exposed to the drug were born with birth defects. The drug, approved by the FDA to only treat nausea and vomiting in cancer patients undergoing chemotherapy and patients who had major surgeries, has been...
